Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia Reply

被引：0
|
作者：
You, Benoit [1 ,2 ,3 ]
Bolze, Pierre-Adrien [1 ,2 ,4 ]
Golfier, Francois [1 ,2 ,4 ]
机构：
[1] Ctr Reference Malad Trophoblast, Lyon, France
[2] Univ Claude Bernard Lyon 1, Univ Lyon, EMR UCBL, HCL 3738, Lyon, France
[3] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Inst Cancerol, Med Oncol,IC HCL,CITOHL, Lyon, France
[4] Hosp Civils Lyon, Serv Chirurg Gynecol & Oncol, Obstet, Ctr Hosp Lyon Sud, Pierre Benite, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 36期
关键词：
PEMBROLIZUMAB; PHASE-3;
D O I：
10.1200/JCO.20.02911
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4350 / +
页数：3
相关论文
共 50 条
  • [41] Comment on single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia
    Mahajan, Niraj N.
    Soni, Rajani N.
    Mahajan, Kshitija N.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (03) : 325 - 325
  • [42] The use of VMP regimen as the first line chemotherapy for low-risk gestational trophoblastic neoplasia
    Cheng, Min
    Lee, Na-Rong
    Wang, Peng-Hui
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2019, 58 (05): : 717 - 718
  • [43] Efficacy of Combination Therapy with Actinomycin D and Methotrexate in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
    Kang, Hai-Li
    Zhao, Qun
    Yang, Shu-Li
    Duan, Wei
    CHEMOTHERAPY, 2019, 64 (01) : 42 - 47
  • [44] UPFRONT HYSTERECTOMY PLUS METHOTREXATE VERSUS CHEMOTHERAPY IN MANAGEMENT OF LOW-RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA IN PATIENTS AT 40 YEARS OR OLDER. A PROSPECTIVE STUDY
    Hemida, Reda
    Othman, Medhat
    Foda, Ashraf
    Eid, Mohammed
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A374 - A374
  • [45] Recurrence and resistance risk factors in low-risk gestational trophoblastic neoplasia
    Branco-Silva, Mariza
    Maesta, Izildinha
    Horowitz, Neil
    Elias, Kevin
    Seckl, Michael
    Berkowitz, Ross
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024,
  • [46] Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: Factors associated with resistance to single-agent methotrexate chemotherapy
    Chapman-Davis, Eloise
    Hoekstra, Anna V.
    Rademaker, Alfred W.
    Schink, Julian C.
    Lurain, John R.
    GYNECOLOGIC ONCOLOGY, 2012, 125 (03) : 572 - 575
  • [47] Management of low-risk gestational trophoblastic neoplasia in indigent women
    Schorge, JO
    Lea, JS
    Farrar, DF
    King, MR
    Coleman, RL
    Miller, DS
    JOURNAL OF REPRODUCTIVE MEDICINE, 2003, 48 (10) : 780 - 784
  • [48] Initial Diagnosis and Treatment of Low-Risk Gestational Trophoblastic Neoplasia
    Alimena, Stephanie
    Elias, Kevin M.
    Horowitz, Neil S.
    Berkowitz, Ross S.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (06) : 1233 - 1244
  • [49] Outcomes for relapsed versus resistant low risk gestational trophoblastic neoplasia following single-agent chemotherapy
    Jareemit, Nida
    Horowitz, Neil S.
    Goldstein, Donald P.
    Berkowitz, Ross S.
    Elias, Kevin M.
    GYNECOLOGIC ONCOLOGY, 2020, 159 (03) : 751 - 757
  • [50] Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia
    Osborne, Raymond J.
    Filiaci, Virginia L.
    Schink, Julian C.
    Mannel, Robert S.
    Behbakht, Kian
    Hoffman, James S.
    Spirtos, Nick M.
    Chan, John K.
    Tidy, John A.
    Miller, David S.
    OBSTETRICS AND GYNECOLOGY, 2016, 128 (03): : 535 - 542
12345